1.
Kim AR, Ulirsch JC, Wilmes S, et al. Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation. Cell. 2017;168(6):1053-1064.e15. doi:10.1016/j.cell.2017.02.026.
1.
Lu J, Guo S, Ebert BL, et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 2008;14(6):843-53. doi:10.1016/j.devcel.2008.03.012.
1.
Ebert BL, Lee MM, Pretz JL, et al. An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarray. Blood. 2005;105(12):4620-6. doi:10.1182/blood-2004-08-3313.
1.
Sankaran VG, Agrawal PB. Stimulating erythropoiesis in neonates. Am J Hematol. 2013;88(11):930-1. doi:10.1002/ajh.23573.
1.
Shen H, Cavallero S, Estrada KD, et al. Extracardiac control of embryonic cardiomyocyte proliferation and ventricular wall expansion. Cardiovasc Res. 2015;105(3):271-8. doi:10.1093/cvr/cvu269.
1.
Burrill DR, Vernet A, Collins JJ, Silver PA, Way JC. Targeted erythropoietin selectively stimulates red blood cell expansion in vivo. Proc Natl Acad Sci U S A. 2016;113(19):5245-50. doi:10.1073/pnas.1525388113.